| Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures D Lavanchy Journal of viral hepatitis 11 (2), 97-107, 2004 | 3670 | 2004 |
| The global burden of hepatitis C D Lavanchy Liver international 29, 74-81, 2009 | 1927 | 2009 |
| Evolving epidemiology of hepatitis C virus D Lavanchy Clinical Microbiology and Infection 17 (2), 107-115, 2011 | 1796 | 2011 |
| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 1746 | 2017 |
| The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt C Frank, MK Mohamed, GT Strickland, D Lavanchy, RR Arthur, ... The Lancet 355 (9207), 887-891, 2000 | 1508 | 2000 |
| Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention D Lavanchy Journal of clinical virology 34, S1-S3, 2005 | 709 | 2005 |
| EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version) TE Jury Journal of Hepatology 39, 3-25, 2003 | 689 | 2003 |
| EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version) TE Jury Journal of Hepatology 39, 3-25, 2003 | 689 | 2003 |
| EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version) TE Jury Journal of Hepatology 39, 3-25, 2003 | 547 | 2003 |
| EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version) TE Jury Journal of Hepatology 39, 3-25, 2003 | 547 | 2003 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 522 | 2014 |
| Global burden of disease (GBD) for hepatitis C Global Burden of Hepatitis C Working Group The Journal of Clinical Pharmacology 44 (1), 20-29, 2004 | 495 | 2004 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 378 | 2014 |
| Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium World Health Organization J Viral Hepat 6, 35-47, 1999 | 358 | 1999 |
| WHO report on global surveillance of epidemic-prone infectious diseases World Health Organization World Health Organization, 2000 | 279 | 2000 |
| Strategies to manage hepatitis C virus (HCV) disease burden H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ... Journal of viral hepatitis 21, 60-89, 2014 | 260 | 2014 |
| KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease: introduction C Alpers, RD Bloom, F Fabrizi, J Izopet, M Jadoul, E Lindley, P Martin, ... Kidney International 73 (suppl. 109), S6-S99, 2008 | 219 | 2008 |
| Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants D FitzSimons, G François, A Hall, B McMahon, A Meheus, A Zanetti, ... Vaccine 23 (32), 4158-4166, 2005 | 181 | 2005 |
| EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B13–14 September, 2002Geneva, Switzerland: Consensus statement (Short version) TE Jury Journal of hepatology 38 (4), 533-540, 2003 | 171 | 2003 |
| Chronic viral hepatitis as a public health issue in the world D Lavanchy Best practice & research Clinical gastroenterology 22 (6), 991-1008, 2008 | 163 | 2008 |
